Behavioral & Cognitive Disorders
Dementia associated with amyotrophic lateral sclerosis
Aug. 11, 2023
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas.
Riluzole is a member of the benzothiazole class and is believed to be a glutamate antagonist. Several other glutamate antagonists (such as dextromethorphan and branched-chain amino acids) have been tried previously for the treatment of amyotrophic lateral sclerosis but without any success. Riluzole is the first drug to be approved for the treatment of amyotrophic lateral sclerosis; it received United States Food and Drug Administration approval in 1995 and was launched in several countries in 1996.
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.